Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LCB01-0371
DRUG
2 trials
Sponsors
LigaChem Biosciences, Inc.
Conditions
Healthy
Phase 1
A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study
Completed
NCT01554995
LigaChem Biosciences, Inc.
Healthy
Start: 2012-03-31
End: 2013-02-28
Updated: 2014-11-17
IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers
Completed
NCT02882789
LigaChem Biosciences, Inc.
Healthy
Start: 2016-09-30
End: 2017-07-31
Updated: 2018-04-10
Related Papers
Single-dose Intravenous Safety, Tolerability, and Pharmacokinetics and Absolute Bioavailability of LCB01-0371.
2018-12-15
8 citations
Pharmacokinetics, Pharmacodynamics, and Tolerability of Single-Dose Oral LCB01-0371, a Novel Oxazolidinone with Broad-Spectrum Activity, in Healthy Volunteers
Antimicrobial Agents and Chemotherapy
2018-04-25
24 citations